HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lita A Freeman Selected Research

Apolipoprotein A-I (Apolipoprotein A1)

1/2018Structural properties of apolipoprotein A-I mimetic peptides that promote ABCA1-dependent cholesterol efflux.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Lita A Freeman Research Topics

Disease

12Lecithin Cholesterol Acyltransferase Deficiency (Lecithin:Cholesterol Acyltransferase Deficiency)
01/2024 - 01/2016
7Atherosclerosis
01/2020 - 11/2006
3Cardiovascular Diseases (Cardiovascular Disease)
01/2023 - 01/2018
2Cholestasis
08/2022 - 01/2020
2Hyperlipoproteinemia Type II (Familial Hypercholesterolemia)
01/2022 - 01/2022
2Acute Coronary Syndrome
01/2020 - 07/2018
2Coronary Disease (Coronary Heart Disease)
11/2018 - 01/2016
2Hypertriglyceridemia
12/2017 - 02/2016
2Anemia
01/2017 - 03/2016
1Liver Diseases (Liver Disease)
01/2024
1Hemolysis
01/2024
1Neoplasms (Cancer)
01/2023
1B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2023
1Lymphocytosis
01/2023
1Hypercholesterolemia
01/2022
1Inborn Genetic Diseases (Disease, Hereditary)
01/2020
1Hyperbilirubinemia
01/2020
1Intrahepatic Cholestasis
01/2020
1Proteinuria
01/2019
1Obesity
01/2019
1Disease Progression
01/2019
1Inflammation (Inflammations)
11/2016
1Corneal Opacity
03/2016
1Nephrosis
01/2016
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2015
1Autoimmune Lymphoproliferative Syndrome
01/2015
1Dyslipidemias (Dyslipidemia)
01/2015
1B-Cell Lymphoma (Lymphoma, B Cell)
01/2015
1Coronary Artery Disease (Coronary Atherosclerosis)
01/2015
1Psoriatic Arthritis
01/2015
1Overweight
10/2012
1Weight Loss (Weight Reduction)
10/2012

Drug/Important Bio-Agent (IBA)

12CholesterolIBA
01/2024 - 11/2006
10Lipoproteins (Lipoprotein)IBA
01/2024 - 11/2006
7Phosphatidylcholine-Sterol O-Acyltransferase (Lecithin Cholesterol Acyltransferase)IBA
01/2020 - 01/2016
6HDL CholesterolIBA
01/2023 - 10/2012
5LipidsIBA
01/2023 - 11/2006
4Lipoprotein-XIBA
01/2024 - 01/2016
4HDL LipoproteinsIBA
01/2023 - 10/2012
3oxidized low density lipoproteinIBA
01/2022 - 10/2012
2ApolipoproteinsIBA
01/2023 - 01/2017
2EnzymesIBA
01/2019 - 03/2016
2Peptides (Polypeptides)IBA
01/2018 - 02/2016
2Apolipoprotein C-II (ApoC2)IBA
12/2017 - 02/2016
2CytokinesIBA
11/2016 - 01/2016
2LDL CholesterolIBA
01/2015 - 10/2012
1BilirubinIBA
01/2024
1Hemoglobins (Hemoglobin)IBA
01/2024
1IntegrinsIBA
01/2023
1Phospholipids (Phosphatides)FDA LinkGeneric
01/2023
1Integrin alpha4beta1 (VLA-4)IBA
01/2023
1Agammaglobulinaemia Tyrosine KinaseIBA
01/2023
1acalabrutinibIBA
01/2023
1phosphatidylethanolamineIBA
01/2023
1Proprotein Convertase 9IBA
01/2022
1LDL Receptors (LDL Receptor)IBA
01/2022
1LecithinsIBA
01/2020
1Alkaline PhosphataseIBA
01/2020
11-Naphthylisothiocyanate (1 Naphthylisothiocyanate)IBA
01/2020
1Filipin (Filipin III)IBA
01/2019
1Biomarkers (Surrogate Marker)IBA
01/2019
1Apolipoprotein A-I (Apolipoprotein A1)IBA
01/2018
1Proteins (Proteins, Gene)FDA Link
01/2018
1PolymersIBA
01/2017
1Cholesterol Esters (Cholesteryl Esters)IBA
01/2017
1Glucose (Dextrose)FDA LinkGeneric
01/2017
1CyclodextrinsIBA
01/2017
1InflammasomesIBA
11/2016
1Apolipoproteins C (ApoC)IBA
02/2016
1Triglycerides (Triacylglycerol)IBA
01/2015
1Scavenger Receptors (Scavenger Receptor)IBA
01/2015
1Interleukin-10 (Interleukin 10)IBA
01/2015
1SterolsIBA
01/2007
1Apolipoproteins B (ApoB)IBA
01/2007
1Ezetimibe (Zetia)FDA Link
01/2007

Therapy/Procedure

6Therapeutics
01/2023 - 02/2016
3Enzyme Replacement Therapy
01/2020 - 07/2018